Press "Enter" to skip to content

New patent for Novo Nordisk drug NOVOLOG PENFILL

0

Annual Drug Patent Expirations for NOVOLOG+PENFILL
Annual Drug Patent Expirations for NOVOLOG+PENFILL

Novolog Penfill is a drug marketed by Novo Nordisk Inc
and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug.

The generic ingredient in NOVOLOG PENFILL is insulin aspart recombinant. Three suppliers are listed for this compound. Additional details are available on the insulin aspart recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Do NOT follow this link or you will be banned from the site!